Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy

Mult Scler. 2009 Nov;15(11):1378-9. doi: 10.1177/1352458509345910.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Chemical and Drug Induced Liver Injury / complications*
  • Chemical and Drug Induced Liver Injury / etiology
  • Female
  • Glatiramer Acetate
  • Humans
  • Ibuprofen / adverse effects*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Interferon Type I / adverse effects*
  • Interferon Type I / therapeutic use
  • Liver Function Tests
  • Multiple Sclerosis / complications*
  • Peptides / adverse effects*
  • Peptides / therapeutic use
  • Recombinant Proteins

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Interferon Type I
  • Peptides
  • Recombinant Proteins
  • Glatiramer Acetate
  • Ibuprofen